サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：凍結乾燥注射剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
市場調査レポート
商品コード
1342746

凍結乾燥注射剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Lyophilized Injectable Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 283 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
凍結乾燥注射剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 283 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

凍結乾燥注射剤市場の世界需要は、2022年の69億3,000万米ドルから2030年には137億3,000万米ドル近くの市場規模に達すると推定され、調査期間2023～2030年のCAGRは8.92%です。

凍結乾燥注射剤は、輸送中も安定した状態を保つ凍結乾燥医薬品です。凍結乾燥注射剤は、溶媒から固形物質を分離するために真空下で溶液を凍結・蒸発させる凍結乾燥プロセスを用いて製造されます。凍結乾燥注射剤は、経口コンクリート製剤の最も効果的な代替品とみなされています。寝たきりの患者は、凍結乾燥注射剤から大きな恩恵を受けています。また、凍結乾燥注射剤は、他の用量よりも保存期間が長いため、様々な障害を患う患者に最大限の吸収と安定性を提供します。

市場力学：

凍結乾燥注射剤市場の成長を促進する重要な要因は、受託研究製造サービスに対する需要の増加と医薬品認可の上昇です。凍結乾燥注射薬の技術改良の増加は、凍結乾燥注射薬の成長を促進すると思われます。凍結乾燥医薬品の規制承認の増加は、凍結乾燥注射薬の需要を刺激する可能性が高いです。凍結乾燥医薬品の製品回収数や包装タイプの増加は、凍結乾燥注射剤市場を制限すると予測されます。注射剤用凍結乾燥バイアルの生産に関連する課題は、これらの医薬品にとって市場成長を制限するものと思われます。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、凍結乾燥注射剤の世界市場における各セグメントを包括的に評価することもできます。凍結乾燥注射剤産業の成長と動向は、この研究に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける凍結乾燥注射剤市場の現在と将来の需要に焦点を当てた地域展望を取り上げます。さらに、本レポートでは、著名な全地域における個々の用途セグメントの需要・推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 凍結乾燥注射剤- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 凍結乾燥注射剤の世界市場分析：包装別

  • 包装別概要
  • 実績データと予測データ
  • 包装別分析
  • 単回使用バイアル
  • ポイントオブケア再構成
  • 特殊包装

第7章 凍結乾燥注射剤の世界市場分析：デリバリー別

  • デリバリー別概要
  • 実績データと予測データ
  • デリバリー別分析
  • プレフィルド希釈液シリンジ
  • 独自の再構成デバイス
  • シングルステップ装置
  • 多段階デバイス

第8章 凍結乾燥注射剤の世界市場分析：適応症別

  • 適応症別概要
  • 実績データと予測データ
  • 適応症別分析
  • 自己免疫疾患
  • 感染症
  • 代謝性疾患
  • その他

第9章 凍結乾燥注射剤の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第10章 凍結乾燥注射剤の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第11章 凍結乾燥注射剤企業の競合情勢

  • 凍結乾燥注射剤市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業シェア分析
  • 市場集中度
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • BD
  • Schott AG
  • Aristopharma Ltd.
  • Vetter Pharma
  • Jubilant HollisterStier LLC
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Packaging (USD MN)
  • Single-use Vials Market Sales by Geography (USD MN)
  • Point-of-care Reconstitution Market Sales by Geography (USD MN)
  • Specialty Packaging Market Sales by Geography (USD MN)
  • Analysis Market by Delivery (USD MN)
  • Prefilled Diluent Syringes Market Sales by Geography (USD MN)
  • Proprietary Reconstitution Devices Market Sales by Geography (USD MN)
  • Single-step Devices Market Sales by Geography (USD MN)
  • Multi-step Devices Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Autoimmune Diseases Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • Metabolic Conditions Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Lyophilized Injectable Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Lyophilized Injectable Report
  • Market Research Process
  • Market Research Methodology
  • Global Lyophilized Injectable Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Packaging
  • Market Attractiveness Analysis by Delivery
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Packaging (USD MN)
  • Single-use Vials Market Sales by Geography (USD MN)
  • Point-of-care Reconstitution Market Sales by Geography (USD MN)
  • Specialty Packaging Market Sales by Geography (USD MN)
  • Global Market Analysis by Delivery (USD MN)
  • Prefilled Diluent Syringes Market Sales by Geography (USD MN)
  • Proprietary Reconstitution Devices Market Sales by Geography (USD MN)
  • Single-step Devices Market Sales by Geography (USD MN)
  • Multi-step Devices Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Autoimmune Diseases Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • Metabolic Conditions Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219936

The global demand for Lyophilized Injectable Market is presumed to reach the market size of nearly USD 13.73 BN by 2030 from USD 6.93 BN in 2022 with a CAGR of 8.92% under the study period 2023 - 2030.

Lyophilized injectables are freeze-dried medications that remain stable during transportation. Lyophilized injectables are created using the lyophilization process, which involves freezing and evaporating a solution under a vacuum to isolate a solid substance from a solvent. Lyophilized injectables are regarded as the most effective alternative to oral concrete dose forms. Bedridden individuals have greatly benefited from lyophilized injectables. Lyophilized injectables also provide maximum absorption and stability in patients suffering from various disorders since they have a longer shelf life than other doses.

MARKET DYNAMICS:

The vital factors driving the growth of the lyophilized injectables market are increased demand for contract research manufacturing services and rising pharmaceutical approvals. The increasing technological improvements in lyophilized injectable medications will likely fuel the growth of lyophilized injectable drugs. The increased regulatory approvals for lyophilized pharmaceuticals will likely stimulate demand for lyophilized injectable medications. The increase in the number of lyophilized medication product recalls and packaging types are projected to restrict the lyophilized injectable market. Factors related to the production of lyophilized vials for injectable products likely pose a challenge for these medications limiting the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of lyophilized injectable. The growth and trends of lyophilized injectable industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the lyophilized injectable market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Packaging

  • Single-Use Vials
  • Point-Of-Care Reconstitution
  • Specialty Packaging

By Delivery

  • Prefilled Diluent Syringes
  • Proprietary Reconstitution Devices
  • Single-Step Devices
  • Multi-Step Devices

By Indication

  • Autoimmune Diseases
  • Infectious Diseases
  • Metabolic Conditions
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Lyophilized Injectable market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lyophilized injectable market include B. Braun Melsungen AG, Baxter International Inc., BD, Schott AG, Aristopharma Ltd., Vetter Pharma, Jubilant HollisterStier LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . LYOPHILIZED INJECTABLE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Packaging
    • 3.7.2 Market Attractiveness Analysis By Delivery
    • 3.7.3 Market Attractiveness Analysis By Indication
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY PACKAGING

  • 6.1 Overview by Packaging
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Packaging
  • 6.4 Single-use Vials Historic and Forecast Sales by Regions
  • 6.5 Point-of-care Reconstitution Historic and Forecast Sales by Regions
  • 6.6 Specialty Packaging Historic and Forecast Sales by Regions

7 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY DELIVERY

  • 7.1 Overview by Delivery
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Delivery
  • 7.4 Prefilled Diluent Syringes Historic and Forecast Sales by Regions
  • 7.5 Proprietary Reconstitution Devices Historic and Forecast Sales by Regions
  • 7.6 Single-step Devices Historic and Forecast Sales by Regions
  • 7.7 Multi-step Devices Historic and Forecast Sales by Regions

8 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY INDICATION

  • 8.1 Overview by Indication
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Indication
  • 8.4 Autoimmune Diseases Historic and Forecast Sales by Regions
  • 8.5 Infectious Diseases Historic and Forecast Sales by Regions
  • 8.6 Metabolic Conditions Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Hospitals Historic and Forecast Sales by Regions
  • 9.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
  • 9.6 Specialty Clinics Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE LYOPHILIZED INJECTABLE COMPANIES

  • 11.1. Lyophilized Injectable Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF LYOPHILIZED INJECTABLE INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. B. Braun Melsungen AG
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Baxter International Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. BD
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Schott AG
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Aristopharma Ltd.
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Vetter Pharma
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Jubilant HollisterStier LLC
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies